Exiger warns the U.S. is overly reliant on foreign countries to make key components of crucial medications as the Trump ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

The pharmaceutical industry is on the brink of massive transformation driven by cutting-edge technology and strategic collaboration. Purdue University is on the forefront of Pharma 4.0 by partnering ...

Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...

Still, some major US pharmaceutical companies have made large investments in domestic manufacturing recently ... with the ...

Piramal Pharma Limited (PPL) is a leading pharmaceutical company and part of the Piramal Group. The company was established ...

Mid-sized Indian pharma firms revamp strategies amid US tariff concerns, focusing on NCDs, API manufacturing, emerging ...

The company is investing hundreds of millions of dollars and will soon start hiring dozens to keep up with the demand for its ...

Donald Trump announced a forthcoming "major" tariff on pharmaceutical imports, aiming to incentivize drug companies to ...